Today

Agents

Chat

Arena

Discover

More

App

CTT Pharmaceutical CEO Ryan Khouri acquires CTTH shares worth $454.5 - CTTH News | Rallies

CTT Pharmaceutical CEO Ryan Khouri acquires CTTH shares worth $454.5

CTTH•2026-09-22

CEO purchases shares in open market

CTT Pharmaceutical Holdings filed a Form 4 showing CEO Ryan Khouri bought 10,100 CTTH shares in open-market purchases.

The shares were acquired at $0.05 each.
His direct holdings rose to 1,056,800 shares following the transaction.

Related News

Euro zone yields fall after Iran raises prospect of Hormuz reopening

TLT•2026-09-22

Hackett Group releases Fall 2026 SolutionMap ranking 122 procurement technology vendors

HCKT•2026-09-22

Pfizer CEO Bourla plans to attend White House state dinner for China's Xi, source says

Sources

S

CTT Pharmaceutical CEO Ryan Khouri acquires CTTH shares worth $454.5

Sec

PFE

•

2026-09-22

FDCTech names Jeff M. Pies, Dena Lauren Decker as directors, effective upon Nasdaq or NYSE listing approval

FDCT•2026-09-22

Banco Bradesco executive officer José Augusto Ramalho Miranda acquires 63,719 common shares for $1.15 million

BBD•2026-09-22